Bright Minds Biosciences (DRUG) Stock Price & Financial Analysis
Bright Minds Biosciences Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Bright Minds Biosciences
What is the current stock price for DRUG?
As of the latest trading session, DRUG stock trades at $71.46. The 52-week range is $23.18–$123.75, with a day range of $68.53–$73.08.
What is the P/E ratio for DRUG?
The P/E ratio (Price-to-Earnings) for DRUG is shown in the Key Statistics section. This valuation metric helps compare Bright Minds Biosciences Inc. to industry peers.
Does DRUG pay dividends?
Bright Minds Biosciences does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for DRUG?
Based on 2 analysts, the consensus for DRUG is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of DRUG?
Bright Minds Biosciences's market capitalization is $554.6M, classifying it as a small-cap company. Bright Minds Biosciences operates in the Healthcare sector within the Biotechnology industry.